Member Info for HarChris

I can see why some placees will have sold into the rise but with so much volume since they’ve had the chance to trim their positions, selling below the placing price when everything is now going to plan would be ludicrous.

So we just need a big buyer and that alone (assuming little selling pressure now) would see a major move north.

The three major updates since October 7th could not realistically be any better, they are about as transformational as it’s possible to be. And yet on October 6th I could buy shares for 0.044p and today at 0.047p, not even 1% more expensive.

Honestly that’s about as irrational as it gets.

The problem remains the huge debt pile and the need for absolutely no missteps or bad luck. Take the recent placing, half a billion shares reduces the debt pile from about €32m to €30m, not even 10%. To recover requires precise execution operationally, profitability across the group, a subsequent rise in share price and then a big raise to bring the debt down meaningfully, but with the knowledge that any major share price rally will lead to a big debt-reducing raise it's unlikely that it'll see such share price appreciation.

A debt spiral is so hard to get out of. If the cashews deliver it's clearly possible but remains an uphill struggle hence still sitting below the deeply depressing placing price.

I'm not an expert but I believe it is a real wall and some of the big investors keep bumping into it. Once they find a way round or come together with tools to knock it down i'm sure 75p will be long gone.

I'm so glad you finally commented after five years to ask such a question. I hope you get the answer your patience to post deserves!

Do you not agree that such rapid expansion alongside a major logistical warehouse and move was always likely to throw up some short term teething issues? As you point out TrustPilot is the sort of place you are more likely to go to if you are seething and with so much going on two dozen customers receiving substandard service is not all that existential?

Until we get a full Ingenuity update we don't know whether the full transition has taken place and so whether it's the old fulfilment or new automatic fulfilment process that is leading to a relative spike in negative reviews but again I think such sweeping conclusions that some are making on here are more to do with the share price action informing that conclusion vs any concrete evidence.

Excellent and comprehensive update, another tick in the derisking box.

Split those proceeds half (1.25p special dividend) to shareholders (and half to go hard at Beutong would suit me - £40m/$52 to work towards a JORC compliant DFS. 4-5 times the contained copper than KSK plus a few million ounces of gold and 20m ounces of silver.

Put that money to good use and it’ll dwarf the value of this recent sale in a few years time.

Looking at EOSE continues to irritate me! -Revenue for the year expected to be ~$155m, a multiplier of almost 36X the $5.7B mcap. On the one hand revenue growth does look mighty impressive ($15.6m year prior) but losses far from narrowing have actually increased with an EBITDA loss in the current quarter a whopping $52.7m! I wondered if the cash position was the reason for the gross disparity... nope $126.8m is a mere fraction of the current mcap and if losses don't narrow significantly that'll be all used up before mid 2026. Not to mention an enormous debt pile so a huge net debt position rather than IES' net cash position (being debt free).

Despite very impressive revenue growth there's no way a company on AIM would be so well supported at such a high market cap if they were failing to make inroads into their losses after such a revenue increase, if anything it would be a red flag. Sucks being UK listed and not on the nasdaq.

And no not at all suspicious when it comes to the rhetoric around the SGC data and as I said to you numerous times earlier this year in a back and forth… to make big returns from here (I think share price was around 40p) all we need is SGC approval and 6103 being as good as CC is bigging it up to be. The latter you seem to be agreeing with now so lots resting on the upcoming data release.

Not so much disappointed, I answered specifically as to what I hoped for during the process. And it’s more to do with the feeling a few months back that we would need a good few trial updates to continue the momentum and see the share price kick on past 50p, they haven’t come and here we are another near 50% higher, I like that. I like that a lot.

What a strange comment Wyn. Currently the share price is rising gradually and you yourself have predicted up to (what was it?) 104p in the near term? The next major catalyst is the SGC data, so you really see both 104p and poor data being released this quarter? Odd juxtaposition to me.

What we have had is Christina absolutely focussed on the P1a SGC data which is a major sign that what they are seeing in the p1b data is excellent, otherwise what do they gain by repeatedly talking up SGC only to have the balloon popped in the coming weeks? None as far as I can tell.

Yes the next trial is the one that looks more likely to ‘revolutionise’ the cancer space but does that mean some smaller indications don’t get approved first in the meantime, drawing in further investment and proving the mechanism of action to bolster the confidence in the pipeline? I think so.

We were never going to get regular updates from what was a short and rapidly executed trial. It’s not like P1a which kept adding cohorts with news needing to be released to keep shareholders interested and informed. Might we have received news of another partial response? Admittedly I hoped so but the share price has managed to rise steadily even without much news whatsoever, a very healthy place for a shareholder. And if the data is good won’t a big reveal later this month or early December have maximum impact? Again I think so.

They’re coming in Q4, we’re barely one third of the way into Q4. Like the below poster said, start wondering what’s happening if we get to Dec 1st without any sort of update but a few days after bonfire night? That’s just being picky for picky’s sake.

Sure it appears the mystery box has gone down like a lead balloon but best to keep things in context, an unhappy customer is more likely to leave a review than a satisfied customer and DD sees thousands of orders per month, 20 bad reviews largely centred around a one-off event (that will be reviewed and discontinued or improved) doesn't allow for such sweeping conclusions.

Yes it HAS reached operational profit, HUD isn't profitable at the group level yet nor did I claim that.

The trajectory is one of becoming ever closer to group profitability so to predict the biggest revenue unit to be mothballed is just odd, it's almost like you're willing the company to fail. Also moaning about going six weeks without a trading update is ridiculous.

I’m sure many consider you the fool for predicting DD is mothballed a few months after it finally reaches operational profitability.

As for a ‘disgraceful’ lack of comms… how? HUD updates every few months, the last TU was six weeks ago, the next will probably be in December unless there’s a specific reason for an RNS or meaningful news to declare to the market.

I thought this was an interesting summary for Creswich JV value:

Medium-Term Value: £0.5-1.5 million (20% Carried Stake .)Implies the full project is worth A$15m (~£7.75m) at earn-in, so ECR's 20% = ~£1.55m (enterprise value basis). This assumes moderate success (e.g., inferred resource of 500-1Moz Au at £2,000/oz gold).

Comparable JVs: Similar Victoria deals (e.g., early-stage earn-ins by mid-tiers like Blackstone Minerals) value at A$10-20m pre-discovery.

Upside Lever: If Bold Gold drills hits (e.g., 1Moz resource), project value could 3-5x to A$50m+, boosting ECR's share to £5m+. But failure (common in exploration; ~70% dry holes) caps at £0.

If we call JV value at this stage ~£1.5m + £2.25m the price initially agreed with Octo fo the tax losses (with obviously far more value to ECR if they can reach profitability) that's three quarters of the current mcap! Valuing Raglan, Blue Mountain & Lolworth at less than £1.5m.

That's quite obviously incredible value in a $4k gold environment.

Reviews on Trust Pilot look decent enough to me on the whole, even recent ones. Score wise 4.1, 4.4 and 4.2 for Discount Dragon, Nutricircle and Boop Beauty respectively.

Last announced gold pour was from mid August. Seems pretty wrong to go nearly three months without sharing production update considering the delicate situation shareholders find themselves in, no?

PIs have absolutely no say in the future of Goldstone now so not sure it's worth getting worked up about. The future is entirely dictated by AIMSL with the gold loan maturing with a debt almost two times the current mcap ie the next steps are whatever AIMSL decide.

The only question worth knowing re this resolution is 'is AIMSL onside?' And you have to hope AIMSL' / Bill's interests align with shareholders.